Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News Baxter announces takeover of Gambro

Baxter announces takeover of Gambro

9th September 2013

Baxter has announced the takeover of Gambro in a deal worth $3.9 billion (2.49 billion pounds), thus enhancing its leadership position in the renal therapies market.

Gambro is a prominent developer of medical technologies and dialysis products and has an extensive reach in territories such as Europe, as well as a broad portfolio of dialysers, devices and dialysis solutions, innovative next-generation monitors and acute therapies for patients with serious kidney, liver and lung conditions.

By combining the two companies' capabilities and product ranges, Baxter will be able to reach a larger number of disease sufferers worldwide.

Coinciding with the announcement, Brik Eyre has been named president of the combined renal business and will become a corporate officer of Baxter.

Robert Parkinson Jr, chairman and chief executive officer of Baxter, said: "The combination of these two respected renal leaders will enable Baxter to better serve healthcare providers and patients through a collective offering of innovative renal products and therapies."

Earlier this year, the company made a new investment in Ocular Therapeutix, a specialist developer of ophthalmic therapeutic products.ADNFCR-8000103-ID-801635182-ADNFCR

We currently have 9 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.